Claudia Paganini

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Genetic profiling of patients with atopic dermatitis reveals immune and skin barrier variants associated with generalized eczema and optimal response to Dupilumab therapy.

Genetic profiling of patients with atopic dermatitis reveals immune and skin barrier variants associated with generalized eczema and optimal response to Dupilumab therapy.

Journal: Frontiers in immunology

Published: January 15, 2026

Predictive Factors of Super-Responder Status to Dupilumab in Adult Atopic Dermatitis: A Real-World Monocentric Study.

Predictive Factors of Super-Responder Status to Dupilumab in Adult Atopic Dermatitis: A Real-World Monocentric Study.

Journal: International journal of dermatology

Published: November 20, 2025

Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictors.

Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictors.

Journal: The Journal of dermatological treatment

Published: November 03, 2025

Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study.

Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study.

Journal: Clinical and experimental dermatology

Published: October 21, 2025

Peripheral blood inflammation indexes correlate with advanced stages in cutaneous melanoma: a single-center retrospective study.

Peripheral blood inflammation indexes correlate with advanced stages in cutaneous melanoma: a single-center retrospective study.

Journal: Melanoma research

Published: July 17, 2025

Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?

Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?

Journal: The Journal of dermatological treatment

Published: June 09, 2025

Real-world effectiveness and safety of lebrikizumab in adults with moderate-to-severe atopic dermatitis: a retrospective observational study with focus on head and neck involvement.

Real-world effectiveness and safety of lebrikizumab in adults with moderate-to-severe atopic dermatitis: a retrospective observational study with focus on head and neck involvement.

Journal: Dermatology reports

Published: May 29, 2025

Could Disease Duration Influence Response to Dupilumab in Patients With Atopic Dermatitis? A Retrospective Real-Life Study.

Could Disease Duration Influence Response to Dupilumab in Patients With Atopic Dermatitis? A Retrospective Real-Life Study.

Journal: International journal of dermatology

Published: May 03, 2025

Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab.

Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab.

Journal: Dermatology reports

Published: April 23, 2025

Safety and Effectiveness Profile of Dupilumab in the Treatment of Atopic Dermatitis in Special Populations.

Safety and Effectiveness Profile of Dupilumab in the Treatment of Atopic Dermatitis in Special Populations.

Journal: Acta dermato-venereologica

Published: April 22, 2025

Safety and Effectiveness Profile of Dupilumab in the Treatment of Atopic Dermatitis in Special Populations.

Safety and Effectiveness Profile of Dupilumab in the Treatment of Atopic Dermatitis in Special Populations.

Journal: Acta dermato-venereologica

Published: April 22, 2025

Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study.

Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study.

Journal: American journal of clinical dermatology

Published: January 29, 2025

Showing 1-12 of 27

Last Updated: 09/26/2026